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Abstract  1 
Study Design: Non-randomized clinical trial (NCT02354625) 2 
Objectives: As part of a Phase I clinical trial to assess the safety of autologous human Schwann 3 
cells (ahSC) in persons with chronic spinal cord injury (SCI), participants engaged in a 4 
multimodal conditioning program pre- and post-ahSC transplantation. The program included a 5 
home-based strength and endurance training program to prevent lack of fitness and post-6 
transplantation detraining from confounding potential ahSC therapeutic effects.  This manuscript 7 
describes development, deployment, outcomes, and challenges of the home-based training 8 
program. 9 
Setting: University-based laboratory 10 
Methods: Development phase: Two men with paraplegia completed an 8-week laboratory based 11 
‘test’ of the home-based program. Deployment phase: The first four (2 males, 2 females) 12 
participant cohort of the ahSC trial completed the program at home for 12 weeks pre- and 20-13 
weeks post-ahSC transplant. 14 
Results: Development phase: Both participants improved their peak aerobic capacity (VO2peak) 15 
(≥17%), peak power output (POpeak) (≥8%) and time to exhaustion (TTE) (≥7%).  Deployment 16 
phase: Pre-transplant training minimally increased fitness in the two male participants (≥6% 17 
POpeak and ≥9% TTE). The two women had no POpeak changes and slight TTE changes (+2.6 and 18 
-1.2%, respectively.) All four participants detrained during the post-transplant recovery period. 19 
After post-transplant re-training, all four participants increased TTE (4-24%), three increased 20 
VO2peak (≥11%), and two increased POpeak (≥7%). 21 




Conclusions: Home-based strength and condition programs can be effective and successfully 22 
included in therapeutic SCI trials. However, development of these programs requires substantial 23 
content knowledge and experience.  24 





The Miami Project to Cure Paralysis conducted a Phase I clinical trial (NCT02354625) to assess 26 
the safety of autologous human Schwann cells (ahSC) as a therapeutic agent for functional 27 
recovery among persons with chronic spinal cord injury (SCI).  As part of this trial, participants 28 
completed a multimodal whole-body conditioning program pre- and post- ahSC transplantation. 29 
This included locomotor training and functional electrical stimulation (FES) performed in the 30 
laboratory and strength and endurance training performed at home.  The goals of the strength and 31 
endurance program were to 1) condition individuals prior to undergoing surgery and 2) prevent a 32 
lack of fitness and/or post-transplantation detraining from confounding potential therapeutic 33 
effects of ahSC transplantation.  The strength and endurance program was specifically developed 34 
for home-based use by the participants.  35 
 36 
The impetus for implementing a home-based program was our experience in a feasibility study 37 
of the multimodal program [1]. That study included body-weight-supported treadmill training for 38 
locomotion (3x weekly), FES for activation of sublesional muscles (3x weekly), and upper body 39 
circuit resistance training (CRT) for strength and endurance conditioning (2x weekly) [1]. 40 
Participants were required to come to the research facility 5 days a week for 19 weeks, which 41 
negatively affected compliance.  Therefore, for the phase I ahSC trial, to reduce participant 42 
burden, mitigate barriers, and increase compliance, we developed a home-based strength and 43 
conditioning program [2]. 44 
 45 
The home-based program used resistance bands (Bodylastics International, Boca Raton, FL) and 46 
dumbbells and was modeled after a laboratory-based CRT protocol [3-5]. Among individuals 47 
with tetraplegia and paraplegia, 40-45 minutes of lab-based CRT performed three times weekly 48 




for 12 weeks improved peak aerobic capacity (VO2peak) and muscular strength by 31% and 21%, 49 
respectively [3-5]. Home-based exercise interventions in individuals with SCI have increased 50 
VO2peak by 13-39% [6-9]. Importantly, home-based program participants achieved nearly 100% 51 
adherence during a 6-12-week commitment [6-8]. Participants indicated that home-based 52 
programs were “convenient”[6] and addressed barriers such as lack of access, transportation, and 53 
time [7], which are often cited as reasons for not participating in clinical trials [2].  54 
 55 
Therefore, the purpose of this manuscript is to describe the development of a home-based 56 
strength and conditioning program; the results of a laboratory-based, proof-of-concept, 8-week 57 
training program (Development phase) using the home-based program; the outcomes of the 58 
home-based program (Deployment phase) for the first four phase I ahSC transplantation trial 59 
participants; and challenges encountered. 60 
 61 
Methods 62 
We first describe methods used in both the Development and Deployment phases followed by 63 
descriptions of methods unique to each phase.  Individuals voluntarily provided written informed 64 
consent and completed the University of Miami Institutional Review Board-approved research 65 
protocol.  Inclusion/exclusion criteria for each study phase are listed in Table 1.  66 
[Table 1] 67 
 68 
Development and Deployment phases shared methods 69 
Peak Aerobic Capacity Assessment: Participants performed a VO2peak assessment using an 70 
electronically braked arm-cycle ergometer (Angio, Lode BV, Gronigen, Netherlands) as 71 




previously reported [10]. Participants were asked to refrain from strenuous activity/alcohol or 72 
caffeine for 12-h prior to testing. Prior to the first test, a staff member interviewed the 73 
participants to determine the individualized wattage starting workload and increments to target a 74 
VO2peak in no more than 12-minutes. The interview included questions regarding the participant’s 75 
current fitness program and general activity level. The starting workload and stage increments 76 
were kept consistent throughout the assessment periods.  Every one-minute workload was 77 
increased until volitional exhaustion manifested as either a non-verbal communication of the 78 
desire to stop or the inability to maintain cadence at 60 ± 5 rpm.   Heart rate (HR) and oxygen 79 
consumption were recorded continuously from baseline through recovery. HR was measured by 80 
standard 12-lead electrocardiography and expiratory gases were collected and analyzed with an 81 
open-circuit metabolic cart (Vmax Encore 29, Care Fusion, San Diego, CA).  Peak oxygen 82 
consumption (VO2peak), peak power output (POpeak) and time to exhaustion (TTE) were selected 83 
for analysis.  84 
 85 
Peak Muscular Strength Assessment 86 
Upper extremity strength testing was performed on a Helms equalizer 1000 multi-station 87 
exerciser (Helm Distributing, Polson, MT) using the following six exercises from the laboratory-88 
based CRT: 1) overhead press, 2) horizontal row, 3) chest fly, 4) biceps curl, 5) latissimus pull-89 
down, and 6) triceps press-down (Table 2). We used an iterative, systematic approach whereby 90 
participants performed one to three sets of three to five repetitions. Weights for the first set were 91 
chosen based on the participant’s injury level, sex, and body weight. Weights for sets two and 92 
three were based on participants’ self-rated effort level of the previous set. One-repetition 93 




maximum (1-RM) was calculated using the Mayhew regression equation [11] which is validated 94 
in persons with SCI [12]:   95 
1-RM = WT/ (0.533 + 0.419E -0.055*REPS) 96 
Where ‘1-RM’ is the estimated one-repetition maximum, ‘WT’ is the resistance used in the last 97 
set where more than three, but fewer than eight repetitions are completed, and ‘REPS’ is the 98 
repetitions completed in the final set.  99 
[Table 2] 100 
Exercise sequencing and conversion 101 
We deemed the frequent switches between aerobic and strength exercises and between different 102 
strength exercises of the laboratory-based CRT program non-feasible for home-based 103 
implementation. We modeled the home-based program exercise sequence after the ‘Tetraplegia’ 104 
CRT [4] concurrent model, which consisted of 10 minutes of aerobic exercise at 60% of heart 105 
rate reserve, followed by all sets of each exercise, and then by 10  minutes of aerobic exercise 106 
also at 60% of heart rate reserve. For all CRT exercises, we first attempted to recreate the 107 
exercise using the resistance band system because it was low-cost, portable, and provided the 108 
widest resistance range.  We converted the shoulder press and bicep curl to dumbbell exercises. 109 
The shoulder press resistance band exercise resulted in a dangerous increase in rearward 110 
instability and the biceps curl resistance band exercise could not be completed with good form in 111 
a full range of motion.  112 
 113 
Prescription Customization Session 114 
The prescription customization session objective was, for each exercise, to identify a resistance 115 
by repetition combination that achieved 1) a target per set work volume, 2) proper form 116 




throughout each repetition, 3) participant stability in their wheelchair, and 4) wheelchair 117 
stability. Per set target work volume was computed as 10 repetitions x load, with load set at 55% 118 
of the predicted 1-RM[13]. This target work volume was the initial volume of the laboratory 119 
based CRT[3].  Figure 1 outlines the iterative process used to identify the band resistance and 120 
repetition combination that achieved all goals.  121 
[Figure 1.] 122 
 123 
Home-based concurrent aerobic and resistance training program 124 
Each 50-minute aerobic and strength training session was performed 3 times weekly on 125 
nonconsecutive days. Participants began with a 2-minute low intensity warm up on a Saratoga 126 
stationary arm cycle (Rand-Scot, Inc, Fort Collins, CO), followed by 10 minutes of vigorous-127 
intensity. They then performed three sets of 10-20 repetitions (based on the customization 128 
session) with no more than 20 seconds between each set for each of the six exercises. Time 129 
between sets mirrored the time allowed in the laboratory-based protocol, which was limited to 130 
the time required for the participants to wheel to the next exercise station (generally ~15-131 
seconds).  Participants finished the session with 10 minutes of vigorous-intensity on the 132 
stationary cycle [4]. Each 10-minute arm cycle block was self-regulated by the talk test.  In order 133 
to elicit a vigorous-intensity level, participants were instructed to maintain an intensity that made 134 
speaking uncomfortable [14]. Every four weeks, participants completed a 1-RM strength 135 
assessment at the laboratory, which was used to increment the target per set work volume and 136 
was accompanied by a prescription customization session.  Participants in both the development 137 
and deployment phases were instructed to maintain their normal activity levels.  138 
 139 




Development phase methods (proof-of-concept training study) 140 
To determine if the home-based program could elicit fitness changes and to determine if 141 
participants could execute the home-based program without staff assistance or guidance, two 142 
men with chronic thoracic SCI (Table 3.) completed an 8-week proof-of-concept study using the 143 
home-based program in a laboratory setting to assess the effect of the program on VO2peak, POpeak 144 
and TTE. Participants completed the program 3 times weekly on nonconsecutive days at the 145 
Miami Project to Cure Paralysis. 146 
 147 
In weeks one through four, investigators provided physical assistance with setting up each 148 
exercise, and verbal guidance regarding form.  Participants began the transition to autonomous 149 
training in week five and were fully autonomous by the end of week six.  During the transition 150 
period, staff provided guidance only when participants struggled to remember the next steps in 151 
the program or were using improper form. To adjust for conditioning effects, participants’ 152 
strength was re-assessed, target workloads were re-computed, and a second prescription 153 
customization session was completed after four weeks.  After 8 weeks, participants completed a 154 
VO2peak assessment. Figure 2A outlines the assessment and intervention timeline for the 155 
Development phase proof-of-concept study. 156 
[Figure 2A-B] 157 
Deployment Phase methods 158 
Four individuals with chronic thoracic SCI (2 men and 2 women) (Table 3) completed the home-159 
based program as a part of their phase I ahSC trial participation.  The home-based training 160 
program was administered for a 12-week pre-transplant conditioning phase with assessments at 161 
baseline (PreTxBL) and one week prior to the transplant (PreTx).  Upon medical clearance, 162 




participants resumed training within one-month post-transplant, and continued until six months 163 
post-transplant with assessments at month two (PostTxM2) and month six (PostTxM6).  Figure 2B 164 
outlines the timeline of assessments and interventions for the Deployment phase. 165 
 166 
At PreTxBL and every four weeks thereafter, participants completed the muscular strength 167 
assessment and an exercise prescription re-customization session. Participants executed the 168 
program in their homes or hotel rooms 3 times weekly on nonconsecutive days. The exercise 169 
band system, dumbbells, and a Saratoga arm crank were provided to each participant.  170 
Participants were supplied with a pictorial exercise guide for reference. Training logs were 171 
completed after each session to confirm compliance.  Prior to the first at home session, a member 172 
of the study team visited the study participant’s home to ensure proper equipment set-up.  173 
 174 
Outcome Measures 175 
Due to small sample size, we present data for each participant at each assessment for both 176 
development and deployment phases. The highest 20-s average was selected as VO2peak (ml/min).  177 
The highest resistance maintained for at least 20 seconds was selected as POpeak (W).  TTE 178 
(minutes:seconds) was recorded as the length of the test. Respiratory exchange ratio (RER), heart 179 
rate (HR) and rate of perceived exertion (RPE) were recorded at peak to confirm that a true peak 180 
was achieved. Results are reported as absolute and percent change. 181 
 182 
Results 183 
Development Phase  184 




Both participants increased peak power output (20.0 and 8.7%), peak oxygen consumption (22.9 185 
and 17.9%), and time to exhaustion (31.5 and 7.1%) (Table 4).  Both participants completed 21 186 
of 24 planned exercise sessions (87.5%), citing illness and scheduling conflicts as reasons for 187 
missing training sessions.  188 
[TABLE 4] 189 
Deployment Phase  190 
Pre-transplant Training Phase: PreTxBL to PreTx  191 
Both men increased POpeak (5.9 and 8.3%) and TTE (9.5 and 13.3%) after the 12 weeks of pre-192 
transplantation conditioning. The two women had no POpeak changes and slight TTE changes 193 
(+2.6 and -1.2%). Interestingly, these minimal effects were accompanied by large divergent 194 
VO2peak changes (+13.7% and -19.8%; Table 4; Figure 3A). Compliance was 92-100% (33-36 195 
completed sessions) for this period. 196 
[FIGURE 3A-C] 197 
Transplant Recovery Phase: PreTx to PostTxM2  198 
AhSC transplant surgery was performed immediately following PreTx assessments.   The 6-199 
week time period following PreTx to PostTxM2 included three to five weeks of post-surgery 200 
recovery followed by resumed training, dependent upon medical clearance.  At PostTxM2, two of 201 
four participants (1M, 1F) experienced a decrease in all outcome measures compared to PreTx, 202 
with all four participants experiencing a decrease (4.8-28.7%) in TTE (Table 4; Figure 3B).  203 
 204 
Post-transplant Training Phase: PostTxM2 to PostTxM6  205 




All four participants increased TTE between months 2 (PostTxM2) and 6 (PostTxM6) (4.8-24.6%), 206 
three increased VO2peak by ≥10%, and two increased POpeak (Table 4, Figure 3C). Compliance 207 
was 90-100% (54-60 sessions) in the 20-week period between PostTxM2 and PostTxM6, 208 
 209 
Adverse events 210 
No adverse events were reported in the development phase. Two participants reported 211 
aggravation of pre-existing joint (shoulder and wrist) pain in the deployment phase. For one of 212 
these participants, study staff decreased the starting wattage for the peak aerobic capacity test by 213 
20 W at PostTxM2 and PostTxM6 (Table 4).  214 
 215 
Discussion 216 
A home-based strength and conditioning program is effective and feasible. Our program 217 
improved fitness pre- and post-ahSC transplant in four individuals with chronic thoracic SCI, but 218 
program effectiveness varied highly. A more robust and universal effect may be achieved by 219 
increasing the volume and precision of the aerobic component. Staff burden was reduced, 220 
compliance was high, and per-participant study expenditures were moderate.  However, there 221 
were significant challenges that must be addressed by any group wishing to mimic this approach.   222 
 223 
General effectiveness  224 
Our results suggest a training effect from pre-transplant training (PreTxBL to PreTx), detraining 225 
following transplant surgery (PreTx to PostTxM2) and finally, a retraining effect after post-226 
transplant training (PostTxM2 to PostTxM6). The largest and most universal improvements 227 
occurred during the post-transplant training period (Fig. 3C.) and were sufficient to ameliorate 228 




post-transplant detraining.  We attribute the larger effects observed in the post vs pre-transplant 229 
periods to the longer training duration (20 vs.12 weeks).  Changes during both training periods 230 
were comparable to those reported in individuals of similar ages and injury levels in previous 231 
studies that have used the laboratory-based CRT [3, 5].  However, the effectiveness of both 232 
periods was highly variable across outcome variables and participants. Such variance is not 233 
unexpected, and can be attributed to many factors, such as, but not limited to variability in 234 
response to an exercise intervention, day-to-day variability in peak performance during testing; 235 
training above/below the prescribed intensity; and insufficient training intensity. 236 
 237 
Variance in effectiveness & proposed solutions 238 
There is strong evidence for considerable natural variation in individual responses (including 239 
non-response) to exercise training programs, even when all research participants are subjected to 240 
the same volume and relative intensity of physical activity[15]. Mean response of a group to an 241 
exercise intervention can mask individual differences in direction and magnitude [15].  As a 242 
hypothetical example, a training study might report a 25% mean gain above baseline values in 243 
VO2max, however, the range of improvement actually varied from no gain to a doubling of 244 
baseline values[16]. It is generally accepted that some individuals are unable to mount a strong 245 
physiological response to an exercise training intervention [17]. The heterogeneity in the 246 
physiological responses to our exercise program may be explained in part by the natural variance 247 
in physiological response to a training stimulus. (Figure 3). However, it may also be explained 248 
by natural test-retest fluctuation and/or error in measurement.  Establishing true and meaningful 249 
individual differences in training programs responses would have required including a 250 
comparator sample and assessing aerobic capacity multiple times at each assessment point. 251 




These features were not possible is this study. As phase I clinical trial, per FDA regulations a 252 
comparator group was not allowed in the ahSC trial. Practical constraints on the cumulative time 253 
burden of testing at each assessment point was a barrier to administering multiple aerobic tests at 254 
each assessment. A week was required to complete all primary (full ISNCSCI motor and sensory 255 
assessments, MRI, pain and sensory assessments, basic blood chemistry) and secondary 256 
(functional, fitness, electrophysiological, autonomic, quality of life and spasticity assessments) 257 
outcomes. 258 
 259 
Nonetheless, a physiologic non-response to exercise in one metric is not indicative of a 260 
ubiquitous non-response. In the deployment phase, despite POpeak and TTE improvements, some 261 
individuals saw no increase or a slight decrease in VO2peak (Figure 3).   The emphasis of strength 262 
over the aerobic component in our home-based program likely favored gains in power over 263 
aerobic capacity. The aerobic component  (60 min/week) falls well below the generally 264 
recommended 150 minutes of moderate-intensity aerobic exercise per week [18, 19],  however, it 265 
does comply with recently published scientific guidelines for improving cardiorespiratory fitness 266 
in adults with SCI [20]. However, aerobic exercise intensity may be more important than 267 
duration. Several studies have reported superior improvements in cardiorespiratory fitness in 268 
individuals with SCI performing vigorous-intensity exercise [21].  Our participants may have 269 
executed the aerobic component at an intensity below the prescribed vigorous-intensity. While 270 
the prescribed duration and intensity of the aerobic component was sufficient for some 271 
participants to improve or maintain their aerobic capacity, it was likely inadequate for 272 
individuals who entered the study with a high aerobic capacity, resulting in a ceiling effect or 273 
even detraining.   274 





We did not consider participants’ current physical activity level when developing the program. 276 
This led to a detraining effect for one deployment phase participant who, prior to relocating for 277 
clinical trial participation, was hand-cycling up to 10 hours each week. This highly trained 278 
individual was accustomed to a significantly greater training volume than our program offered, 279 
was unable to maintain his pre-trial weekly hand cycling program, and thus did not maintain his 280 
initial fitness level.  Detraining can occur if the program training volume is less than the 281 
participant’s current dosing.  Thus, future implementations in any domain, including FES or gait 282 
training, should be flexible enough to achieve conditioning gains in under-conditioned persons 283 
and maintain the conditioning of persons who enter the trial at a supra-optimal status. In 284 
addition, each individual’s response to the training stimulus should be reassessed frequently in 285 
order to intensify training for non-responders.   286 
 287 
Compliance, participant-staff burden, program materials cost 288 
High program compliance was consistent with interventions of similar content and duration [6-289 
8].  However, compliance was an explicitly stated expectation for trial participation. Individuals 290 
who presented themselves as candidates were removed from consideration if there was any doubt 291 
about their willingness and ability to comply with the multi-modal pre and post-transplant 292 
training.  Additionally, all participants were required to be of “average” or greater fitness 293 
classification [22] to undergo transplantation. Study participants were informed of their current 294 
fitness classification following baseline testing and were likely motivated to complete the 295 
training in order to maintain or achieve the minimum fitness required to undergo transplantation 296 
surgery. In this particular cohort, both male participants fell in the “excellent” fitness category at 297 




baseline and maintained that throughout the trial.  One female participant was above median and 298 
one below at baseline. The female who was below median at baseline (and thus not initially 299 
eligible to undergo transplantation) improved to above median after pre-transplant conditioning 300 
and was approved for surgery.  301 
 302 
Participant and staff burden were decreased as a result of the home-based program. Participants 303 
did not express that they felt overburdened, in fact, 3 of 4 participants requested permission to 304 
perform more physical activity.  305 
 306 
The average cost per participant (paid for by the trial) was $2,160-2,258 (United States Dollars). 307 
This includes the arm cycle ($1920), resistance bands and door anchor ($198), and dumbbells 308 
($42-140). 309 
 310 
Home-based program development and deployment challenges 311 
We encountered multiple sets of challenges during home-based program development and 312 
deployment. The first set included maintaining participant stability in the chair and stability of 313 
the wheelchair itself.  We used 55% of 1-RM values calculated during the 1-RM assessment as a 314 
starting point to set resistive loads on the band training system. This resistance resulted in a 315 
complete loss of balance when the maneuver was performed bilaterally due to lack of trunk 316 
motor control.  Therefore we switched to performing the exercises unilaterally which also 317 
resulted in a complete loss of balance. To solve this problem we switched to a volume based 318 
paradigm, which allowed us to reduce the resistance to a level that enabled the participant to 319 
maintain stability by using their ipsilateral arm to grab their chair.  However, even when 320 




participant stability was maintained, the wheelchair often slid across the low friction tile floor 321 
towards the anchor point of the bands. This problem was solved for all participants by requiring 322 
the resistance band system be installed in a room with a carpeted floor.  If this is not possible, 323 
individuals can place a small mat on a low friction floor or, if they are able to,  place wood 2x4s 324 
in front of the rear wheels.   325 
 326 
The second set was ensuring participants could independently perform all exercises at home with 327 
the prescribed resistance and correct form. Band resistance is dependent on the degree of stretch, 328 
which in turn is dependent on how far the individual is from the band’s anchor point, and thus 329 
must be consistent across training sessions. During the prescription customization session, for 330 
each maneuver, the wheelchair’s position relative to and distance from the anchor point was 331 
documented. When participants returned home, they marked the wheelchair position for each 332 
exercise on the floor with a piece of tape, which enabled consistent band resistance across 333 
sessions.  Customization sessions were also used to correct and coach participants on proper 334 
form, and included key tips for each exercise.  To further facilitate compliance, participants were 335 
provided with a packet after each customization session that described for each exercise where to 336 
place tape markers, which bands to use, the anchor points, the required number of sets and reps, 337 
photos of the start and end positions and training logs for each session. If requested, a staff 338 
member travelled back to the participant’s residence after each prescription customization 339 
session to check the tape markers and band system set-up. For exercises where the tape markers 340 
resulted in a position more than an arm length from the band anchor, a piece of rope was tied to 341 
the resistance band’s handle. Participants placed the rope in their lap while they assumed the 342 
prescribed position and then used the rope to pull the handle towards them.  Finally, to prevent 343 




the participant from having to re-configure the bands for each exercise during the session, a 344 
unique set of bands were provided for each exercise. The bands for each exercise were attached 345 
to the anchor system after each customization session and remained in place until the next 346 
prescription customization session.  347 
 348 
To our knowledge, these challenges have not been specifically reported by other studies 349 
investigating the use of a home-based band resistance training program [8, 23] in individuals 350 
with SCI. In a case series [8], the participant spent 90 minute with study staff learning the details 351 
and correct form for the exercises and establishing the proper band resistance.  Band resistance 352 
was established by identifying a challenging load during the last 3 repetitions in a set of 10 [8]. 353 
An earlier study used 50% of 1-RM established on the laboratory-based CRT exercises to 354 
convert into band resistance equivalents by attaching 20-cm loops of band to a calibrated 355 
tensiometer [23]. The authors of previous studies did not specifically address any challenges 356 
regarding chair stability or the ability to achieve the desired training volume using these 357 
methods.   358 
 359 
Methodological weaknesses and limitations 360 
The small sample size limits statistical analysis as well as generalizability of findings, however, 361 
this limitation is inherent to all phase I trials.  Participation in this clinical trial required that 362 
participants relocated to the Miami area for 10 months. This substantial environmental change 363 
likely affected general living habits, especially diet and exercise/rehabilitation participation, for 364 
which we did not account.  Our compliance monitoring was based on self-report and therefore 365 
we could not verify that each session was actually performed.  Finally, testing bias was possible, 366 




as the investigator performing the prescription customizations was also, at times, conducting 367 
VO2peak assessments.  Ideally, the individual conducting the VO2peak assessment would be 368 
blinded to the prescription customization and to the participants’ mid-assessment progress.  369 
 370 
Conclusions 371 
Home-based strength and condition programs can be successfully included in therapeutic SCI 372 
trials and can be effective to achieve target fitness levels. However, development of these 373 
programs requires substantial content knowledge and experience. In addition, for each mode of a 374 
multi-modal condition program designed to support an intervention, future studies should 375 
strongly consider customizing training loads for highly trained persons in addition to a 376 
standardized training load for non-trained participants.  377 
 378 
Data Archiving All data generated and analyzed in this study are available from the 379 
corresponding author on request.  380 
 381 
Funding This work was supported by The Miami Project to Cure Paralysis, Buoniconti Fund to 382 
Cure Paralysis, and the Bryon Riesch Paralysis Foundation.   383 
 384 
Author Contributions All authors were responsible for research conception and design and 385 
critical review and revision of the article.  JM, RC, and KA were involved converting the CRT 386 
exercises to band/dumbbell exercises. JM was additionally involved in data collection, analysis 387 
and drafting this manuscript.   388 
 389 




Acknowledgements The authors would like to acknowledge the work of Kathleen Nagle.  390 
 391 
Statement of Ethics We certify that all applicable institutional and governmental regulations 392 
concerning the ethical use of human volunteers were followed during the course of this research.  393 
 394 
Conflicts of Interest The authors declare that they have no conflicts of interest.  395 
 396 
References 397 
1. Gant KL, Nagle KG, Cowan RE, Field-Fote EC, Nash MS, Kressler J et al. Body System 398 
Effects of a Multi-Modal Training Program Targeting Chronic, Motor Complete Thoracic 399 
Spinal Cord Injury. J Neurotrauma 2018; 35(3): 411-423. 400 
 401 
2. Anderson KD, Cowan RE, Horsewell J. Facilitators and Barriers to Spinal Cord Injury 402 
Clinical Trial Participation: Multi-National Perspective of People Living with Spinal 403 
Cord Injury. J Neurotrauma 2016; 33(5): 493-499. 404 
 405 
3. Jacobs PL, Nash MS, Rusinowski JW. Circuit training provides cardiorespiratory and 406 
strength benefits in persons with paraplegia. Medicine and science in sports and exercise 407 
2001; 33(5): 711-717. 408 
 409 
4. Kressler J, Burns PA, Betancourt L, Nash MS. Circuit training and protein 410 
supplementation in persons with chronic tetraplegia. Medicine and science in sports and 411 
exercise 2014; 46(7): 1277-1284. 412 
 413 
5. Nash MS, van de Ven I, van Elk N, Johnson BM. Effects of circuit resistance training on 414 
fitness attributes and upper-extremity pain in middle-aged men with paraplegia. Archives 415 
of physical medicine and rehabilitation 2007; 88(1): 70-75. 416 
 417 
6. Lai B, Rimmer J, Barstow B, Jovanov E, Bickel CS. Teleexercise for Persons With 418 
Spinal Cord Injury: A Mixed-Methods Feasibility Case Series. JMIR Rehabil Assist 419 
Technol 2016; 3(2): e8. 420 
 421 
7. Nightingale TE, Walhin JP, Thompson D, Bilzon JLJ. Impact of Exercise on 422 
Cardiometabolic Component Risks in Spinal Cord-injured Humans. Medicine and 423 
science in sports and exercise 2017; 49(12): 2469-2477. 424 





8. Sasso E, Backus D. Home-based circuit resistance training to overcome barriers to 426 
exercise for people with spinal cord injury: a case study. J Neurol Phys Ther 2013; 37(2): 427 
65-71. 428 
 429 
9. Ma JK, West CR, Martin Ginis KA. The Effects of a Patient and Provider Co-Developed, 430 
Behavioral Physical Activity Intervention on Physical Activity, Psychosocial Predictors, 431 
and Fitness in Individuals with Spinal Cord Injury: A Randomized Controlled Trial. 432 
Sports medicine 2019; 49(7): 1117-1131. 433 
 434 
10. Maher JL, Cowan RE. Comparison of 1- Versus 3-Minute Stage Duration During Arm 435 
Ergometry in Individuals With Spinal Cord Injury. Archives of physical medicine and 436 
rehabilitation 2016. 437 
 438 
11. Mayhew JL, Prinster JL, Ware JS, Zimmer DL, Arabas JR, Bemben MG. Muscular 439 
endurance repetitions to predict bench press strength in men of different training levels. J 440 
Sports Med Phys Fitness 1995; 35(2): 108-113. 441 
 442 
12. Ribeiro Neto F, Guanais P, Dornelas E, Coutinho ACB, Costa RRG. Validity of one-443 
repetition maximum predictive equations in men with spinal cord injury. Spinal cord 444 
2017; 55(10): 950-956. 445 
 446 
13. Benson C, Docherty D, Brandenburg J. Acute neuromuscular responses to resistance 447 
training performed at different loads. Journal of science and medicine in sport / Sports 448 
Medicine Australia 2006; 9(1-2): 135-142. 449 
 450 
14. Cowan RE, Ginnity KL, Kressler J, Nash MS, Nash MS. Assessment of the talk test and 451 
rating of perceived exertion for exercise intensity prescription in persons with paraplegia. 452 
Topics in spinal cord injury rehabilitation 2012; 18(3): 212-219. 453 
 454 
15. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. 455 
Medicine and science in sports and exercise 2001; 33(6): S446-S451. 456 
 457 
16. Bouchard C. Individual differences in the response to regular exercise. Int J Obes Relat 458 
Metab Disord 1995; 19 Suppl 4: S5-8. 459 
 460 
17. Timmons JA. Variability in training-induced skeletal muscle adaptation. Journal of 461 
applied physiology 2011; 110(3): 846-853. 462 
 463 
18. Clinical Practice Guidelines: Spinal Cord Medicine. In: Identification and Management 464 
of Cardiometabolic Risk after Spinal Cord Injury, 2018. 465 





19. American College of Sports Medicine, Riebe D, Ehrman JK, Liguori G, Magal M. 467 
ACSM's guidelines for exercise testing and prescription, Tenth edition. edn Wolters 468 
Kluwer Health: Philadelphia, PA, 2018. 469 
 470 
20. Martin Ginis KA, van der Scheer JW, Latimer-Cheung AE, Barrow A, Bourne C, 471 
Carruthers P et al. Evidence-based scientific exercise guidelines for adults with spinal 472 
cord injury: an update and a new guideline. Spinal cord 2018; 56(4): 308-321. 473 
 474 
21. Nightingale TE, Metcalfe RS, Vollaard NB, Bilzon JL. Exercise Guidelines to Promote 475 
Cardiometabolic Health in Spinal Cord Injured Humans: Time to Raise the Intensity? 476 
Archives of physical medicine and rehabilitation 2017; 98(8): 1693-1704. 477 
 478 
22. Simmons OL, Kressler J, Nash MS. Reference fitness values in the untrained spinal cord 479 
injury population. Archives of physical medicine and rehabilitation 2014; 95(12): 2272-480 
2278. 481 
 482 
23. Nash MS, Jacobs PL, Woods JM, Clark JE, Pray TA, Pumarejo AE. A comparison of 2 483 
circuit exercise training techniques for eliciting matched metabolic responses in persons 484 
with paraplegia. Archives of physical medicine and rehabilitation 2002; 83(2): 201-209. 485 
 486 
 487 
Figure Legends 488 
Figure 1. Flow chart describing the iterative process used for each exercise to identify the 489 
combination of resistance and repetitions that achieved the target workload. 490 
Figure 2. Timeline of assessment and interventions for the A.) Development Phase and B). 491 
Deployment Phase. BL, baseline; Post, post-training; PreTxBL, Pre-treatment Baseline; PreTx, 492 
Pre-transplant; PostTxM2, Post-transplant Month 2; PostTxM6, Post-transplant Month 6. 493 
Figure 3. Percent change across deployment phase assessments: A.) PreTxBL to PreTx, B.) PreTx 494 
to PostTxM2, C.) PostTxM2 to PostTxM6.  PreTxBL, Pre-treatment Baseline; PreTx, Pre-transplant; 495 
PostTxM2, Post-transplant Month 2; PostTxM6, Post-transplant Month 6; PO, power output; VO2, 496 
oxygen consumption; TTE, time to exhaustion.  PO VO2 TTE 497 
 498 
Table Legends 499 
Table 1. Inclusion Exclusion Criteria 500 
Table 2. Strengthening exercises used in laboratory and home-based programs. Anatomical 501 
movement, main muscles activated, and home-based resistance mode are indicated. 502 




Table 3.  Participant descriptive characteristics.  BL, baseline; Post, post-training; kg, kilogram; 503 
cm, centimeter; BMI, body mass index; km, kilometer; m, meter; M, male; F, female; yrs, years; 504 
AIS, American Spinal Injury Association Impairment Scale; PreTxBL, Pre-treatment Baseline; 505 
PreTx, Pre-transplant; PostTxM2, Post-transplant Month 2; PostTxM6, Post-transplant Month 6.   506 
Table 4.  Physiological responses to arm ergometry testing (values at test termination).  PreTxBL, 507 
Pre-treatment Baseline; PreTx, Pre-transplant; PostTxM2, Post-transplant Month 2; PostTxM6, 508 
Post-transplant Month 6; BL, baseline; Post, post-training; M, male; F, female; POpeak, peak 509 
power output; VO2peak, peak oxygen consumption; RER, respiratory exchange ratio; HR, heart 510 
rate; %max, % of age predicted max HR; RPE, rate of perceived exertion; TTE, time to 511 
exhaustion; W, watts; ml/min, milliliters per minute; ml/kg.min, milliliters per kg body weight 512 
per minute; min:sec, minutes: seconds. a Testing parameters were modified (20 W decrease in 513 
starting W) secondary to non-study related shoulder pain. 514 
Figure 1. Flow chart describing the iterative process used for each exercise to identify the combination of 



















Figure 2. A-B. Timeline of assessment and interventions for the A.) Development Phase and B). Deployment Phase.   
 
Figure 3. A-C  Percent change across deployment phase assessments 
 
 
Table 1. Inclusion Exclusion Criteria 
 
Inclusion/Exclusion Criteria Development Phase Deployment Phasea Deployment Phase
a 
(transplant surgery) 
Inclusion Criteria  
Persons with traumatic SCI that 
occurred a minimum of 12 months 
prior to enrollment 
 √ 
 
Persons with SCI/D that occurred a 




Between the ages of 18 and 65 at last 
birthday √ √ 
 
SCI between spinal levels C5-T12 as 
defined by the most caudal level of 
intact motor and sensory function on 
the International Standards for 
Neurological Classification of Spinal 
Cord Injury (ISNCSCI) 
√ √ 
 
ASIA Impairment Scale (AIS) grade 
A, B, or C at time of enrollment √ √ 
 
Lesion length ≤ 3 cm and lesion 




Exclusion Criteria  
Persons unable to safely undergo an 
MRI  √ 
 
Persons with penetrating injury of the 
spinal cord or complete transection of 
the cord, as identified by MRI 
 √ 
 
Persons with severe, uncorrected 
post-injury spinal deformity and/or 




Persons with a cavity structure that 
would preclude successful 
transplantation, as identified by MRI 
 √ 
 
Persons with syringomyelia – defined 
as patients with progressively 
enlarging cysts on T2 weighted 




Intolerance to functional electrical 
stimulation of muscles  √ 
 
Exercise induced abnormalities  √  
Range of motion of the upper or lower 
extremities outside functional limits for 




Evidence of bone or joint pathology 
that adversely influences participation 




Fracture, dislocation, or extremity 
instruments (implanted or external) 
that adversely influences participation 




Unhealed pressure ulcer √ √  
History of documented seizures, 
stroke, brain tumor, serious head 
injury, or any other intracranial 
problem that could increase the risk 




Pregnant women or a positive 
pregnancy test in those women with 




Presence of disease that might 
interfere with participant safety, 
compliance, or evaluation of the 
condition under study 
 √ 
 
Body Mass Index (BMI) ≥ 35  √  
History of active substance abuse  √  
Persons who are current participants 
in any interventional trial  √ 
 
Persons with a history of prior 




Persons allergic to gentamicin  √  
Persons who test positive for HIV or 
Hepatitis B or C virus  √ 
 
Persons with lab values significantly 




Persons who can independently 
ambulate √ √ 
 
Persons who gain the ability to 
independently ambulate after 
completing the 12 week fitness and 
rehabilitation protocol 
  √ 
Failure to achieve a fitness level in or 
above the ‘average’ category 
established for persons with chronic 
paraplegia or chronic tetraplegia20  
  √ 
Failure to obtain cultured SC that 
meet lot release criteria   √ 
Active medical conditions precluding 
safe transplantation   √ 
aInclusion/exclusion criteria for phase I clinical trial (NCT02354625) 
 
Table 2.  Strengthening exercises used in laboratory and home-based programs. Anatomical movement, 
main muscles activated, and home-based resistance mode are indicated. 





press   
Shoulder abduction with 
scapular elevation and upward 
rotation  
Anterior & medial deltoids, 
triceps Dumbbell 
Horizontal row Shoulder horizontal abduction with scapular adduction 
Erector spinae, trapezius, 
rhomboids, latissimus dorsi, 
teres major, posterior deltoids 
Resistance band 
Chest fly  
Shoulder horizontal adduction 
while in external rotation to the 
midline 
Pectoralis major & minor Resistance band 




Shoulder adduction with 
scapular downward rotation and 
depression 
Latissimus dorsi, rhomboids, 





Shoulder flexion, scapular 
depression and elbow extension Triceps, deltoids Resistance band 
 
  
BL, baseline; Post, post-training; kg, kilogram; cm, centimeter; BMI, body mass index; km, kilometer; m, meter; M, male; F, female; 
yrs, years; AIS, American Spinal Injury Association Impairment Scale; PreTxBL, Pre-treatment Baseline; PreTx, Pre-transplant; 
PostTxM2, Post-transplant Month 2; PostTxM6, Post-transplant Month 6.   
 





















1 BL 54.5 170 18.8 20.0 M 21 T3/A 3 Post 57.8 






M 46 T10/A 15 PreTx 84.0 29.0 PostTxM2 96.0 29.7 





F 31 T2/A 1 PreTx 66.0 23.5 PostTxM2 66.0 23.5 





F 52 T10/C 10 PreTx 63.0 22.4 PostTxM2 63.0 22.4 





M 27 T11/B 2 PreTx 71.5 20.2 PostTxM2 70.7 20.0 

















PreTxBL, Pre-treatment Baseline; PreTx, Pre-transplant; PostTxM2, Post-transplant Month 2; PostTxM6, Post-transplant Month 6; BL, 
baseline; Post, post-training; M, male; F, female; POpeak, peak power output; VO2peak, peak oxygen consumption; RER, respiratory 
exchange ratio; HR, heart rate; %max, % of age predicted max HR; RPE, rate of perceived exertion; TTE, time to exhaustion; W, 
watts; ml/min, milliliters per minute; ml/kg.min, milliliters per kg body weight per minute; min:sec, minutes: seconds. a Testing 
parameters were modified (20 W decrease in starting W) secondary to non-study related shoulder pain. 
 




 POpeak W 
VO2peak   
ml/min 










1 BL 50 874 16.0 0.95 182 (91) 20 4:30 Post 60 852 14.7 1.34 188 (94) * 5:55 




PreTxBL 170 2905 35.0 1.22 168 (97) 16 8:46 
PreTx 180 2864 34.1 1.27 163 (94) 20 9:36 
PostTxM2 150 2460 28.6 1.35 173 (99) 20 6:48a 
PostTxM6 160 2745 31.3 1.29 175 (100) 19 8:05a 
107 (F) 
PreTxBL 40 488 7.5 1.23 134 (71) 12 4:32 
PreTx 40 554 8.4 1.21 143 (76) 20 4:39 
PostTxM2 30 535 8.1 1.35 140 (74) 7 3:19 
PostTxM6 40 606 8.8 1.33 155 (82) 14 4:08 
111 (F) 
PreTxBL 65 982 14.5 1.36 155 (92) 15 7:05 
PreTx 65 788 12.5 1.45 150 (89) 15 7:00 
PostTxM2 65 901 14.3 1.19 141 (84) 15 6:40 
PostTxM6 65 1093 17.0 1.24 149 (92) 14 7:08 
113 (M) 
PreTxBL 120 2032 26.6 1.51 201 (104) 16 10:40 
PreTx 130 2188 30.6 1.33 203 (105) 18 12:05 
PostTxM2 140 2248 31.8 1.36 191 (99) 17 10:30 
PostTxM6 140 2187 30.8 1.41 198 (103) 16 11:00 
*This data needs to be obtained from study hardcopy files stored in the laboratory. Due to the current COVID-19 pandemic, we do not 
have access to them.  We should be able to fill in the blanks for these 2 missing data points by the time the proofs come out. 
